Variants in the membrane protein complement receptor 1 (CR1) and the plasma regulator clusterin (CLU) genes of the complement pathway trigger late-onset AD, which is responsible for 95% of AD cases [104,106,107,108]. Here, CR1 is linked to Alzheimer disease.